Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 265

1.

Rationalization of the Membrane Permeability Differences in a Series of Analogue Cyclic Decapeptides.

Witek J, Wang S, Schroeder B, Lingwood R, Dounas A, Roth HJ, Fouché M, Blatter M, Lemke O, Keller B, Riniker S.

J Chem Inf Model. 2019 Jan 28;59(1):294-308. doi: 10.1021/acs.jcim.8b00485. Epub 2018 Dec 4.

PMID:
30457855
2.

Association of Nonoxidized Parathyroid Hormone with Cardiovascular and Kidney Disease Outcomes in Chronic Kidney Disease.

Seiler-Mussler S, Limbach AS, Emrich IE, Pickering JW, Roth HJ, Fliser D, Heine GH.

Clin J Am Soc Nephrol. 2018 Apr 6;13(4):569-576. doi: 10.2215/CJN.06620617. Epub 2018 Mar 5.

PMID:
29507005
3.

Partial Body UV Exposure in Chronic Kidney Disease and Extrarenal Vitamin D Metabolism.

Krause R, Stange R, Roth HJ, Kaase H, Michalsen A, Holick MF.

Anticancer Res. 2018 Feb;38(2):1217-1219.

PMID:
29374760
4.
5.

Fibroblast Growth-factor 23 and Calcium-binding Proteins are not Associated with Chronic Itch in Patients on Haemodialysis.

Mettang T, Kunzmann K, Roth HJ, Weisshaar E.

Acta Derm Venereol. 2017 Mar 10;97(3):381-382. doi: 10.2340/00015555-2536. No abstract available.

6.

Design and Development of a Cyclic Decapeptide Scaffold with Suitable Properties for Bioavailability and Oral Exposure.

Fouché M, Schäfer M, Berghausen J, Desrayaud S, Blatter M, Piéchon P, Dix I, Martin Garcia A, Roth HJ.

ChemMedChem. 2016 May 19;11(10):1048-59. doi: 10.1002/cmdc.201600082. Epub 2016 May 6.

PMID:
27154275
7.

Pharmacokinetic Studies around the Mono- and Difunctionalization of a Bioavailable Cyclic Decapeptide Scaffold.

Fouché M, Schäfer M, Blatter M, Berghausen J, Desrayaud S, Roth HJ.

ChemMedChem. 2016 May 19;11(10):1060-8. doi: 10.1002/cmdc.201600083. Epub 2016 Apr 20.

PMID:
27094987
8.

Biochemical markers of bone turnover in patients with spinal metastases after resistance training under radiotherapy--a randomized trial.

Rief H, Omlor G, Akbar M, Bruckner T, Rieken S, Förster R, Schlampp I, Welzel T, Bostel T, Roth HJ, Debus J.

BMC Cancer. 2016 Mar 17;16:231. doi: 10.1186/s12885-016-2278-1.

9.

Vitamin D Status in Chronic Kidney Disease - UVB Irradiation Is Superior to Oral Supplementation.

Krause R, Roth HJ, Kaase H, Stange R, Holick MF.

Anticancer Res. 2016 Mar;36(3):1397-401.

PMID:
26977042
10.

Hydroxymethyl Salicylaldehyde Auxiliary for a Glycine-Dependent Amide-Forming Ligation.

Fouché M, Masse F, Roth HJ.

Org Lett. 2015 Oct 16;17(20):4936-9. doi: 10.1021/acs.orglett.5b02350. Epub 2015 Oct 1.

PMID:
26425998
11.

Serum sclerostin and DKK1 in relation to exercise against bone loss in experimental bed rest.

Belavý DL, Baecker N, Armbrecht G, Beller G, Buehlmeier J, Frings-Meuthen P, Rittweger J, Roth HJ, Heer M, Felsenberg D.

J Bone Miner Metab. 2016 May;34(3):354-65. doi: 10.1007/s00774-015-0681-3. Epub 2015 Jun 9.

PMID:
26056021
12.

Associations of serum 25-hydroxycholecalciferol and parathyroid hormone with serum lipids differ by sex and vitamin D status.

Jungert A, Roth HJ, Neuhäuser-Berthold M.

Public Health Nutr. 2015 Jun;18(9):1684-91. doi: 10.1017/S1368980014002286. Epub 2014 Oct 30.

PMID:
25355402
13.

Automated Competitive Protein-Binding Assay for Total 25-OH Vitamin D, Multicenter Evaluation and Practical Performance.

Wielders JP, Carter GF, Eberl H, Morris G, Roth HJ, Vogl C.

J Clin Lab Anal. 2015 Nov;29(6):451-61. doi: 10.1002/jcla.21793. Epub 2014 Aug 17.

PMID:
25132191
14.

Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4.

Seiler S, Rogacev KS, Roth HJ, Shafein P, Emrich I, Neuhaus S, Floege J, Fliser D, Heine GH.

Clin J Am Soc Nephrol. 2014 Jun 6;9(6):1049-58. doi: 10.2215/CJN.07870713. Epub 2014 Mar 27.

15.

Soluble α-klotho and its relation to kidney function and fibroblast growth factor-23.

Scholze A, Liu Y, Pedersen L, Xia S, Roth HJ, Hocher B, Rasmussen LM, Tepel M.

J Clin Endocrinol Metab. 2014 May;99(5):E855-61. doi: 10.1210/jc.2013-4171. Epub 2014 Feb 25.

PMID:
24606097
16.

S-adenosylhomocysteine is associated with subclinical atherosclerosis and renal function in a cardiovascular low-risk population.

Zawada AM, Rogacev KS, Hummel B, Berg JT, Friedrich A, Roth HJ, Obeid R, Geisel J, Fliser D, Heine GH.

Atherosclerosis. 2014 May;234(1):17-22. doi: 10.1016/j.atherosclerosis.2014.02.002. Epub 2014 Feb 18.

PMID:
24589563
17.

Cyclic carbo-isosteric depsipeptides and peptides as a novel class of peptidomimetics.

Guéret SM, Meier P, Roth HJ.

Org Lett. 2014 Mar 7;16(5):1502-5. doi: 10.1021/ol5003797. Epub 2014 Feb 26.

PMID:
24571727
18.

Muscle atrophy, pain, and damage in bed rest reduced by resistive (vibration) exercise.

Miokovic T, Armbrecht G, Gast U, Rawer R, Roth HJ, Runge M, Felsenberg D, Belavý DL.

Med Sci Sports Exerc. 2014 Aug;46(8):1506-16. doi: 10.1249/MSS.0000000000000279.

PMID:
24561811
19.

Do depressed patients without activation of the hypothalamus-pituitary-adrenal (HPA) system have metabolic disturbances?

Scharnholz B, Gilles M, Marzina A, Kommer M, Lederbogen F, Wudy SA, Hartmann MF, Westphal S, Roth HJ, Kahl KG, Meyer-Lindenberg A, Michaely HJ, Deuschle M.

Psychoneuroendocrinology. 2014 Jan;39:104-10. doi: 10.1016/j.psyneuen.2013.09.030. Epub 2013 Oct 18.

PMID:
24275009
20.

Nonoxidized, biologically active parathyroid hormone determines mortality in hemodialysis patients.

Tepel M, Armbruster FP, Grön HJ, Scholze A, Reichetzeder C, Roth HJ, Hocher B.

J Clin Endocrinol Metab. 2013 Dec;98(12):4744-51. doi: 10.1210/jc.2013-2139. Epub 2013 Oct 30.

PMID:
24171919
21.

Modeling of oxidized PTH (oxPTH) and non-oxidized PTH (n-oxPTH) receptor binding and relationship of oxidized to non-oxidized PTH in children with chronic renal failure, adult patients on hemodialysis and kidney transplant recipients.

Hocher B, Oberthür D, Slowinski T, Querfeld U, Schaefer F, Doyon A, Tepel M, Roth HJ, Grön HJ, Reichetzeder C, Betzel C, Armbruster FP.

Kidney Blood Press Res. 2013;37(4-5):240-51. doi: 10.1159/000350149. Epub 2013 Jul 14.

22.

cobas 8000 Modular analyzer series evaluated under routine-like conditions at 14 sites in Australia, Europe, and the United States.

von Eckardstein A, Roth HJ, Jones G, Preston S, Szekeres T, Imdahl R, Conti M, Blanckaert N, Jose D, Thiery J, Feldmann L, von Ahsen N, Locatelli M, Kremastinou J, Kunst A, Hubbuch A, McGovern M.

J Lab Autom. 2013 Aug;18(4):306-27. doi: 10.1177/2211068212472183. Epub 2013 Jan 14.

PMID:
23321915
23.

Changes in bone metabolic parameters in children with chronic myeloid leukemia on imatinib treatment.

Jaeger BA, Tauer JT, Ulmer A, Kuhlisch E, Roth HJ, Suttorp M.

Med Sci Monit. 2012 Dec;18(12):CR721-8.

24.

Increase in soluble CD95L during subacute phases after human spinal cord injury: a potential therapeutic target.

Biglari B, Büchler A, Swing T, Biehl E, Roth HJ, Bruckner T, Schmidmaier G, Ferbert T, Gerner HJ, Moghaddam A.

Spinal Cord. 2013 Mar;51(3):183-7. doi: 10.1038/sc.2012.139. Epub 2012 Nov 27.

PMID:
23184030
25.

Plasma Klotho is not related to kidney function and does not predict adverse outcome in patients with chronic kidney disease.

Seiler S, Wen M, Roth HJ, Fehrenz M, Flügge F, Herath E, Weihrauch A, Fliser D, Heine GH.

Kidney Int. 2013 Jan;83(1):121-8. doi: 10.1038/ki.2012.288. Epub 2012 Aug 15.

26.

Measuring parathyroid hormone (PTH) in patients with oxidative stress--do we need a fourth generation parathyroid hormone assay?

Hocher B, Armbruster FP, Stoeva S, Reichetzeder C, Grön HJ, Lieker I, Khadzhynov D, Slowinski T, Roth HJ.

PLoS One. 2012;7(7):e40242. doi: 10.1371/journal.pone.0040242. Epub 2012 Jul 6.

27.

Treatment with mirtazapine and venlafaxine increases noradrenaline excretion in depressed patients.

Lecei O, Lederbogen F, Gronau W, Scharnholz B, Terhardt J, Schilling C, Gilles M, Kopf D, Roth HJ, Weber-Hamann B, Deuschle M.

J Clin Psychopharmacol. 2012 Aug;32(4):574-6. doi: 10.1097/JCP.0b013e31825ddf1b. No abstract available.

PMID:
22760352
28.

Serum 25-hydroxyvitamin D3 and body composition in an elderly cohort from Germany: a cross-sectional study.

Jungert A, Roth HJ, Neuhäuser-Berthold M.

Nutr Metab (Lond). 2012 May 18;9(1):42. doi: 10.1186/1743-7075-9-42.

29.

Serum 25-hydroxyvitamin D3, parathyroid hormone and blood pressure in an elderly cohort from Germany: a cross-sectional study.

Jungert A, Roth HJ, Neuhäuser-Berthold M.

Nutr Metab (Lond). 2012 Mar 21;9(1):20. doi: 10.1186/1743-7075-9-20.

30.

Vitamin D status and mortality of German hemodialysis patients.

Krause R, Schober-Halstenberg HJ, Edenharter G, Haas K, Roth HJ, Frei U.

Anticancer Res. 2012 Jan;32(1):391-5.

PMID:
22213331
31.

Impact of oral ibandronate 150 mg once monthly on bone structure and density in post-menopausal osteoporosis or osteopenia derived from in vivo μCT.

Bock O, Börst H, Beller G, Armbrecht G, Degner C, Martus P, Roth HJ, Felsenberg D.

Bone. 2012 Jan;50(1):317-24. doi: 10.1016/j.bone.2011.10.027. Epub 2011 Oct 30.

PMID:
22067902
32.

Recent trends and observations in the design of high-quality screening collections.

Renner S, Popov M, Schuffenhauer A, Roth HJ, Breitenstein W, Marzinzik A, Lewis I, Krastel P, Nigsch F, Jenkins J, Jacoby E.

Future Med Chem. 2011 Apr;3(6):751-66. doi: 10.4155/fmc.11.15. Review.

PMID:
21554080
33.

The effects of bed-rest and countermeasure exercise on the endocrine system in male adults: evidence for immobilization-induced reduction in sex hormone-binding globulin levels.

Belavý DL, Seibel MJ, Roth HJ, Armbrecht G, Rittweger J, Felsenberg D.

J Endocrinol Invest. 2012 Jan;35(1):54-62. doi: 10.3275/7606. Epub 2011 Mar 21.

PMID:
21422800
34.

Additive impact of alfacalcidol on bone mineral density and bone strength in alendronate treated postmenopausal women with reduced bone mass.

Felsenberg D, Bock O, Börst H, Armbrecht G, Beller G, Degner C, Stephan-Oelkers M, Schacht E, Mazor Z, Hashimoto J, Roth HJ, Martus P, Runge M.

J Musculoskelet Neuronal Interact. 2011 Mar;11(1):34-45.

35.

TRACP 5b and CTX as osteological markers of delayed fracture healing.

Moghaddam A, Müller U, Roth HJ, Wentzensen A, Grützner PA, Zimmermann G.

Injury. 2011 Aug;42(8):758-64. doi: 10.1016/j.injury.2010.11.017. Epub 2010 Dec 17.

PMID:
21168135
36.

Multicenter evaluation of a new automated electrochemiluminescence immunoassay for the quantification of testosterone compared to liquid chromatography tandem mass spectrometry.

Brandhorst G, Streit F, Kratzsch J, Schiettecatte J, Roth HJ, Luppa PB, Körner A, Kiess W, Binder L, Oellerich M, von Ahsen N.

Clin Biochem. 2011 Feb;44(2-3):264-7. doi: 10.1016/j.clinbiochem.2010.09.024. Epub 2010 Oct 12.

PMID:
20923677
37.

Are commonly recommended dosages for vitamin D supplementation too low? Vitamin D status and effects of supplementation on serum 25-hydroxyvitamin D levels--an observational study during clinical practice conditions.

Leidig-Bruckner G, Roth HJ, Bruckner T, Lorenz A, Raue F, Frank-Raue K.

Osteoporos Int. 2011 Jan;22(1):231-40. doi: 10.1007/s00198-010-1214-5. Epub 2010 Jun 17.

PMID:
20556359
38.

Lacking evidence for calcium-binding protein fetuin-A to be linked with chronic kidney disease-related pruritus (CKD-rP).

Mettang T, Matterne U, Roth HJ, Weisshaar E.

NDT Plus. 2010 Feb;3(1):104-5. doi: 10.1093/ndtplus/sfp161. No abstract available.

39.

Preoperative shock wave therapy reduces ischemic necrosis in an epigastric skin flap model.

Reichenberger MA, Germann G, Roth HJ, Meirer R, Engel H.

Ann Plast Surg. 2009 Dec;63(6):682-4. doi: 10.1097/SAP.0b013e31819ae048.

PMID:
19816153
40.

First automated assay for thyrotropin receptor autoantibodies.

Gassner D, Stock W, Golla R, Roth HJ.

Clin Chem Lab Med. 2009;47(9):1091-5. doi: 10.1515/CCLM.2009.245.

PMID:
19634982
41.

Resistive vibration exercise attenuates bone and muscle atrophy in 56 days of bed rest: biochemical markers of bone metabolism.

Armbrecht G, Belavý DL, Gast U, Bongrazio M, Touby F, Beller G, Roth HJ, Perschel FH, Rittweger J, Felsenberg D.

Osteoporos Int. 2010 Apr;21(4):597-607. doi: 10.1007/s00198-009-0985-z. Epub 2009 Jun 18.

PMID:
19536451
42.

[Current and permanent, easily readable work. Vitamins--a question and answer game between a young student and an old professor].

Roth HJ.

Pharm Unserer Zeit. 2009;38(2):118-24. doi: 10.1002/pauz.200800302. Review. German. No abstract available.

PMID:
19248017
43.

New highly sensitivity assay used to measure cardiac troponin T concentration changes during a continuous 216-km marathon.

Giannitsis E, Roth HJ, Leithäuser RM, Scherhag J, Beneke R, Katus HA.

Clin Chem. 2009 Mar;55(3):590-2. doi: 10.1373/clinchem.2008.116566. No abstract available.

44.

Clinical value of the first automated TSH receptor autoantibody assay for the diagnosis of Graves' disease (GD): an international multicentre trial.

Schott M, Hermsen D, Broecker-Preuss M, Casati M, Mas JC, Eckstein A, Gassner D, Golla R, Graeber C, van Helden J, Inomata K, Jarausch J, Kratzsch J, Miyazaki N, Moreno MA, Murakami T, Roth HJ, Stock W, Noh JY, Scherbaum WA, Mann K.

Clin Endocrinol (Oxf). 2009 Oct;71(4):566-73. doi: 10.1111/j.1365-2265.2008.03512.x. Epub 2008 Dec 17.

PMID:
19170704
45.

Technical evaluation of the first fully automated assay for the detection of TSH receptor autoantibodies.

Hermsen D, Broecker-Preuss M, Casati M, Mas JC, Eckstein A, Gassner D, van Helden J, Inomata K, Jarausch J, Kratzsch J, Mann K, Miyazaki N, Navarro Moreno MA, Murakami T, Roth HJ, Noh JY, Scherbaum WA, Schott M.

Clin Chim Acta. 2009 Mar;401(1-2):84-9. doi: 10.1016/j.cca.2008.11.025. Epub 2008 Dec 3.

PMID:
19091299
46.

Now you see it, now you don't--the hidden life of cerebral dural arteriovenous fistulae.

Brasse G, Roth HJ, Fritzsch D, Scheid R.

Neuroradiology. 2009 Feb;51(2):131-3. doi: 10.1007/s00234-008-0481-8. Epub 2008 Dec 13. No abstract available.

PMID:
19082996
47.

Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population.

Graser A, Stieber P, Nagel D, Schäfer C, Horst D, Becker CR, Nikolaou K, Lottes A, Geisbüsch S, Kramer H, Wagner AC, Diepolder H, Schirra J, Roth HJ, Seidel D, Göke B, Reiser MF, Kolligs FT.

Gut. 2009 Feb;58(2):241-8. doi: 10.1136/gut.2008.156448. Epub 2008 Oct 13.

PMID:
18852257
48.

Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography-tandem mass spectrometry as a reference.

Roth HJ, Schmidt-Gayk H, Weber H, Niederau C.

Ann Clin Biochem. 2008 Mar;45(Pt 2):153-9. doi: 10.1258/acb.2007.007091.

PMID:
18325178
49.

Roche Elecsys Prolactin II assay: reactivity with macroprolactin compared with eight commercial assays for prolactin and determination of monomeric prolactin by precipitation with polyethylene glycol.

Fahie-Wilson M, Bieglmayer C, Kratzsch J, Nusbaumer C, Roth HJ, Zaninotto M, Plebani M, Hubbuch A, Schneider E.

Clin Lab. 2007;53(7-8):485-92.

PMID:
17821956
50.

Roche Elecsys Prolactin II assay: reactivity with macroprolactin compared with eight commercial assays for prolactin and determination of monomeric prolactin by precipitation with polyethylene glycol.

Fahie-Wilson M, Bieglmayer C, Kratzsch J, Nusbaumer C, Roth HJ, Zaninotto M, Plebani M, Hubbuch A, Schneider E.

Clin Lab. 2007;53(5-6):301-7.

PMID:
17605405

Supplemental Content

Support Center